SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

SVB Leerink Reiterates Outperform on BridgeBio Pharma, Lowers Price Target to $39

SVB Leerink reiterates BridgeBio Pharma (NASDAQ:BBIO) with a Outperform and lowers the price target from $41 to $39.

Benzinga · 05/14/2020 12:25

SVB Leerink reiterates BridgeBio Pharma (NASDAQ:BBIO) with a Outperform and lowers the price target from $41 to $39.